Author

Yan Zhang

Observed names: Yan Zhang¹, Zhang, Yan
Observed institutions: Jiangsu University, Tongji University, University of Maryland, Baltimore, University of Minnesota, Children's National, Harvard University, Harbin Medical University, Sun Yat-sen University, Guangxi Medical University, China Three Gorges University, China Pharmaceutical University, Henan University, Guangdong Medical College, Shenzhen University, Baylor College of Medicine, Shanghai Jiao Tong University, Jilin University, Anhui Medical University, Chinese Academy of Sciences, Peking University, Harbin Institute of Technology, Nankai University, Sichuan University, West China Medical Center of Sichuan University, Renji Hospital, Tianjin Medical University Cancer Institute and Hospital, Chinese PLA General Hospital, Henan University Huaihe Hospital and Huaihe Clinical Institute, West China Second University Hospital of Sichuan University, West China Hospital of Sichuan University, Bristol-Myers Squibb (United States), Zhejiang Cancer Hospital, Shandong Tumor Hospital, Nanfang Hospital, Shenzhen Maternity and Child Healthcare Hospital, Shanghai Institutes for Biological Sciences, First People's Hospital of Kunshan, Weifang People's Hospital, Dana-Farber Cancer Institute, First Affiliated Hospital of Guangdong Pharmaceutical University, Chinese People's Armed Police General Hospital, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Dongguan People’s Hospital, Jiangsu Cancer Hospital, Henan Provincial People's Hospital, University of Hong Kong - Shenzhen Hospital, Second Affiliated Hospital of Jilin University, Guangdong Province Women and Children Hospital, Guangdong Academy of Medical Sciences, Central Hospital of Zibo, Yichang Central People's Hospital, Shandong Provincial QianFoShan Hospital, Guangdong Provincial People's Hospital, State Key Laboratory of Respiratory Disease, Tumor Hospital of Guangxi Medical University, First Affiliated Hospital of Zhengzhou University, Tongji Hospital, Shandong First Medical University, Masonic Cancer Center, State Key Laboratory of Microbial Metabolism, Chinese People's Armed Police Force, Second Affiliated Hospital of Nantong University, 3D Medicines, Inc. (China), Hangzhou Institute of Medicine, Chinese Academy of Sciences, CStone Pharmaceuticals (China), Jounce Therapeutics (United States), Cangzhou Medical College, Zhengzhou Urban Construction Vocational College, Tianjin Medical University, Southern Medical University, Nanjing Medical University, Guangzhou Medical University, Air Force Medical University
ORCID: 0000-0002-5027-6430
Observed ORCIDs: 0000-0002-5027-6430, 0000-0002-5307-2484
OpenAlex ID: A5100456259
2018 · Xuexiang Du, Fei Tang, et al. · Cell Research · 249
2012 · Noah Weisleder, Norio Takizawa, et al. · Science Translational Medicine · 211
2010 · Ashley K. Tehranchi, Matthew D. Blankschien, et al. · Cell · 148
2020 · Yu-Sheng Shi, Yan Zhang, et al. · Journal of Functional Foods · 120
2013 · Nonyelum Harcourt, Rahel G. Ghebre, et al. · Journal of Immigrant and Minority Health · 83
2019 · Tsuyoshi Hata, Hasan Rajabi, et al. · Molecular Cancer Therapeutics · 55
2016 · Wang Jing, Miaomiao Li, et al. · OncoTargets and Therapy · 48
2019 · Yan Zhang, Wei‐kang Yang, et al. · Molecular Genetics & Genomic Medicine · 42
2018 · Peipei Ma, Shu Zhang, et al. · Orphanet Journal of Rare Diseases · 34
2020 · Fang Zhang, Pengyi Yan, et al. · Cell Reports · 27
2022 · Lian-sheng Cheng, Yong-feng Cheng, et al. · Journal of Translational Medicine · 19
Works count: 96
Citation count: 2,443
H-index: 23
I10-index: 43
Year
Topic
Type